These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 2659775)
1. Anticonvulsant activities of 1-phenylcyclohexylamine and its conformationally restricted analog 1,1-pentamethylenetetrahydroisoquinoline. Rogawski MA; Thurkauf A; Yamaguchi S; Rice KC; Jacobson AE; Mattson MV J Pharmacol Exp Ther; 1989 Jun; 249(3):708-12. PubMed ID: 2659775 [TBL] [Abstract][Full Text] [Related]
2. Anticonvulsant 1-phenylcycloalkylamines: two analogues with low motor toxicity when orally administered. Blake PA; Yamaguchi S; Thurkauf A; Rogawski MA Epilepsia; 1992; 33(1):188-94. PubMed ID: 1531130 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and anticonvulsant activity of 1-phenylcyclohexylamine analogues. Thurkauf A; de Costa B; Yamaguchi S; Mattson MV; Jacobson AE; Rice KC; Rogawski MA J Med Chem; 1990 May; 33(5):1452-8. PubMed ID: 2329567 [TBL] [Abstract][Full Text] [Related]
4. Anticonvulsant activity of the low-affinity uncompetitive N-methyl-D- aspartate antagonist (+-)-5-aminocarbonyl-10,11-dihydro-5H- dibenzo[a,d]cyclohepten-5,10-imine (ADCI): comparison with the structural analogs dizocilpine (MK-801) and carbamazepine. Rogawski MA; Yamaguchi S; Jones SM; Rice KC; Thurkauf A; Monn JA J Pharmacol Exp Ther; 1991 Oct; 259(1):30-7. PubMed ID: 1920122 [TBL] [Abstract][Full Text] [Related]
5. Anticonvulsant activity of novel derivatives of 2- and 3-piperidinecarboxylic acid in mice and rats. Hinko CN; Crider AM; Kliem MA; Steinmiller CL; Seo TH; Ho B; Venkatarangan P; el-Assadi AA; Chang H; Burns CM; Tietz EI; Andersen PH; Klitgaard H Neuropharmacology; 1996; 35(12):1721-35. PubMed ID: 9076751 [TBL] [Abstract][Full Text] [Related]
6. The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor. Tricklebank MD; Singh L; Oles RJ; Preston C; Iversen SD Eur J Pharmacol; 1989 Aug; 167(1):127-35. PubMed ID: 2550253 [TBL] [Abstract][Full Text] [Related]
7. Anticonvulsant profiles of the potent and orally active GABA uptake inhibitors SK&F 89976-A and SK&F 100330-A and four prototype antiepileptic drugs in mice and rats. Swinyard EA; White HS; Wolf HH; Bondinell WE Epilepsia; 1991; 32(4):569-77. PubMed ID: 1831122 [TBL] [Abstract][Full Text] [Related]
8. Characterization of 3-carboxy-5-phosphono-1,2,3,4-tetrahydroisoquinoline (SC-48981), a potent competitive N-methy-D-aspartate (NMDA) receptor antagonist, in vitro and in vivo. Vazquez ML; Garland DJ; Sun ET; Cler JA; Mick SJ; Hood WF; Monahan JB; Iyengar S; Rao TS Neurosci Lett; 1992 Feb; 135(2):149-52. PubMed ID: 1352628 [TBL] [Abstract][Full Text] [Related]
9. Classification of compounds for prevention of NMDLA-induced seizures/mortality, or maximal electroshock and pentylenetetrazol seizures in mice and antagonism of MK801 binding in vitro. Palmer GC; Harris EW; Ray R; Stagnitto ML; Schmiesing RJ Arch Int Pharmacodyn Ther; 1992; 317():16-34. PubMed ID: 1456842 [TBL] [Abstract][Full Text] [Related]
11. Anticonvulsant properties of calcium channel blockers in mice: N-methyl-D-,L-aspartate- and Bay K 8644-induced convulsions are potently blocked by the dihydropyridines. Palmer GC; Stagnitto ML; Ray RK; Knowles MA; Harvey R; Garske GE Epilepsia; 1993; 34(2):372-80. PubMed ID: 7681002 [TBL] [Abstract][Full Text] [Related]
12. Selective blockade of N-methyl-D-aspartate (NMDA)-induced convulsions by NMDA antagonists and putative glycine antagonists: relationship with phencyclidine-like behavioral effects. Koek W; Colpaert FC J Pharmacol Exp Ther; 1990 Jan; 252(1):349-57. PubMed ID: 2153806 [TBL] [Abstract][Full Text] [Related]
13. D-23129: a new anticonvulsant with a broad spectrum activity in animal models of epileptic seizures. Rostock A; Tober C; Rundfeldt C; Bartsch R; Engel J; Polymeropoulos EE; Kutscher B; Löscher W; Hönack D; White HS; Wolf HH Epilepsy Res; 1996 Apr; 23(3):211-23. PubMed ID: 8739124 [TBL] [Abstract][Full Text] [Related]
14. Solubilization of rat brain phencyclidine receptors in an active binding form that is sensitive to N-methyl-D-aspartate receptor ligands. Ambar I; Kloog Y; Sokolovsky M J Neurochem; 1988 Jul; 51(1):133-40. PubMed ID: 2898002 [TBL] [Abstract][Full Text] [Related]
15. Behavioral studies on FR115427, a novel selective N-methyl-D-aspartate antagonist. Nakanishi H; Katsuta K; Ueda Y; Takasugi H; Kuno A; Ohkubo M; Ogita K; Yoneda Y; Shirakawa K; Yoshida K Psychopharmacology (Berl); 1995 Jan; 117(2):172-7. PubMed ID: 7753964 [TBL] [Abstract][Full Text] [Related]